BioCrossroads Book of Data and Organizations goes digital to serve as Indiana’s wiki for health data assets

2023-05-09T16:06:42-04:00May 9, 2023|

INDIANAPOLIS (May 9, 2023) – BioCrossroads today released the seventh edition of its Book of Data and Organizations and announced that the resource used to foster collaboration and networking among Indiana’s growing network of healthcare and life sciences companies, organizations and professionals, will now be available only in digital form on the organizations’ website under the Resources/Network tab. “This resource has quintupled in size since we first created it in 2020 and is used to help health data professionals and others become more aware of the data, talent, and technology resources available, and build solutions where there are gaps,” said Darshan Shah, senior vice president and chief data officer for BioCrossroads. “Now, as a wiki, it will be an even better resource to help drive collaboration across the sector.” Indiana’s life sciences sector contributed $77 billion to the state’s economic [...]

BioCrossroads adds new members to Board of Directors 

2023-04-30T14:29:50-04:00April 27, 2023|

INDIANAPOLIS (April 27, 2023) – BioCrossroads, Indiana’s initiative to grow the state’s life sciences sector, today announced seven new members to its board of directors. Central Indiana Corporate Partnership (CICP) President Latoya Botteron Purdue University Indianapolis Launch Leader Daniel J. Hasler Central Indiana Corporate Partnership CEO Melina Kennedy Langham Logistics Inc. Founder, Owner and President Cathy Langham University of Notre Dame Professor and Dean of the College of Science Santiago Schnell Indiana University Provost and Executive Vice President Rahul Shrivastav LabCorp Drug Development Senior Vice President – Head of Enterprise Client Solution and Business Strategy Stacey Yount  “We are delighted to welcome these leaders and innovators to our board and look forward to benefiting from their vast experience, skills and intellect,” said Dan Peterson, board chair for BioCrossroads. “Indiana’s life sciences sector has experienced tremendous growth over the past 20 [...]

BioCrossroads releases 2022 Indiana Life Sciences Capital Report showing $6.8B in capital investment in the life sciences sector  

2023-04-17T08:34:34-04:00April 17, 2023|

INDIANAPOLIS (April 17, 2023) — BioCrossroads today released its annual analysis of capital invested to grow and support Indiana life sciences companies in 2022. “We are pleased to report that Indiana experienced capital investment of more than $6.8 billion in 2022 that will directly result in the creation of 3,000 new life sciences sector jobs in the state,” said Jane Dunigan-Smith, BioCrossroads’ senior vice president, chief strategy officer and managing director of Seed Funds. “This includes more than $600 million in venture capital to support innovation and start-ups along with $2.8 billion in other capital investments for establishing, expanding or upgrading Indiana life sciences facilities.” Indiana’s life sciences sector contributed $77 billion to the state’s economy last year. Total market cap value grew by 20 percent over 2021, from $455.7 billion to $548.7 billion, driven largely by Eli Lilly and [...]

IBJ: Life Sciences Industry Booster BioCrossroads Girds for New Challenges

2023-03-31T09:19:03-04:00March 27, 2023|

A recent Indianapolis Business Journal (IBJ) article takes a look back at 20 years of success for BioCrossroads, the life sciences initiative of the Central Indiana Corporate Partnership (CICP). In two decades, BioCrossroads has assisted more than 500 startup companies, raised more than $600 million of market capital and helped attract thousands of jobs. In 2022, data shows that Indiana leads the United States in pharmaceutical sales and is one of three top states for exports of all life sciences products - pharmaceuticals, medical devices, and agbiosciences, while providing an $80 billion economic impact. In 2023, BioCrossroads announced that President and CEO Patty Martin would step down to pursue other ventures. “I think it’s just a logical time right now to take a couple of months and really take a good hard, informed look at where we are overall,” said [...]

BioCrossroads names new members to leadership team

2023-03-21T15:25:53-04:00March 21, 2023|

INDIANAPOLIS (March 21, 2023) — BioCrossroads announced today that Jane Dunigan-Smith and Mike Bolinder have joined the organization’s leadership team. Dunigan-Smith, senior vice president, chief strategy officer and managing director of Seed Funds, comes to BioCrossroads after 19 years with Eli Lilly and Company where she spent a significant portion of her career in commercialization, corporate strategy and operations. She also has a strong background in accounting and finance, having spent the early part of her career as a Certified Public Accountant, and serves on the boards of Diagnotes, Inc. and Allinaire Therapeutics. “Jane’s multi-faceted experience positions her to manage the Seed Funds and lead our strategy at a time when Indiana’s life sciences sector is expanding and innovating in multiple areas,” said Patty Martin, president and CEO, BioCrossroads. “One example is our work to establish Indiana as a global [...]

White Paper: Recruiting and retaining talent who make life-saving medicine; State of Pharmaceutical Manufacturing Workforce in Indiana

2023-03-09T09:52:35-05:00March 9, 2023|

Indiana is experiencing significant statewide growth in pharmaceutical manufacturing (Indiana ranks #1 in the nation for pharmaceutical exports) but this boom in high-quality, high-paying jobs is challenged by a shortage of qualified workers. BioCrossroads, in partnership with Ascend Indiana, convened pharmaceutical manufacturers, postsecondary education institutions, and state officials to explore how to develop a robust talent pipeline to support continued growth. The two initiatives have released the following white paper: Recruiting and retaining talent who make life-saving medicine: State of the Pharmaceutical Manufacturing Workforce in Indiana [READ WHITE PAPER]

Indiana leads the U.S. in pharmaceutical exports

2023-03-02T14:39:58-05:00March 2, 2023|

INDIANAPOLIS (March 2, 2023) -- Indiana leads the United States in pharmaceutical exports, according to new data from the Indiana Business Research Center at the Indiana University Kelley School of Business. Life sciences exports have always been a strong area for the state. Indiana has been one of the top three states in exports for all life sciences products – pharmaceuticals, medical device, and agbiosciences -- for more than a decade. In 2022, $13 billion of these products were shipped all over the world. In addition, 2022 saw a record amount of venture capital raised by Indiana start-ups for the third straight year – increasing to $620 million, an increase of nearly $200 million from 2021. Other key indicators and statistics for 2022 include: The economic output of the state’s life sciences industry was $77 billion, driven by more than [...]

BioCrossroads releases 2022 Annual Report

2023-03-09T09:09:22-05:00March 2, 2023|

2022 was a year for celebration for BioCrossroads, not only because the life sciences sector continued strong growth and success, but because it was the organization’s 20th anniversary which marked a time to not only reflect on past accomplishments and achievements, but to also look forward to the future of the industry and the next generation of talent. MASSIVE MARKET KNOWLEDGE BioCrossroads undertook an ambitious year of coordinating and releasing capital and economic impact reports; profiles of innovators and change makers; and tracking the organization’s two decades of work – publishing ten reports in all. TOUTING TALENT To honor the next generation of life sciences leaders, BioCrossroads developed the 23 PAIR (Promising Achievers in Innovation and Research) recognition program in 2022. ENGAGING THROUGH EVENTS With more than 100 events developed and hosted over the last two decades, BioCrossroads took advantage [...]

Go to Top